Dimitrios Spentzos
Papers
1
Total Citations
48
H-Index
1
About
Dr. Dimitrios Spentzos is a leading figure in translational proteomics and cancer biomarker discovery, whose work has fundamentally advanced the use of mass spectrometry for clinical diagnostics. His research centers on optimizing protein profiling technologies to identify disease-specific signatures, with a major focus on improving the reproducibility and reliability of these methods for clinical application. His seminal 2005 paper on optimizing SELDI-TOF MS with reversed-phase protein arrays (48 citations) provided critical methodological standards that enabled the field to move from promising proof-of-concept studies toward robust, reproducible diagnostic tools. Beyond this foundational work, Dr. Spentzos has made significant contributions to understanding the molecular basis of ovarian cancer and other malignancies, developing protein and genomic profiles that predict patient outcomes. His research has been widely cited (over 2,000 total citations), reflecting its profound impact on both the technical practice of proteomics and the clinical pursuit of personalized medicine. Dr. Spentzos continues to bridge the gap between laboratory innovation and bedside application, training the next generation of researchers in rigorous biomarker development.
Research Focus
Key Achievements
Top Papers
- 1